Persistent hypogammaglobulinemia after rituximab therapy in pediatric patients, prevalence and clinical outcomes

Hypogammaglobulinemia is a known side effect of rituximab (RTX) in adults, but its prevalence and persistence in children remain underexplored. This retrospective cohort study at a tertiary care center examines the prevalence and clinical outcomes of hypogammaglobulinemia in pediatric patients after...

Full description

Bibliographic Details

Published in:	Clinical Immunology Communications
Main Authors:	Susanna P.C. Höppener, Saskia R. Veldkamp, Mark C.H. de Groot, Saskia Haitjema, Julia Drylewicz, Jaap Jan Boelens, Caroline A. Lindemans, Joris van Montfrans, Annet van Royen-Kerkhof, Marc H.A. Jansen
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Subjects:	Hypogammaglobulinemia Rituximab Pediatric B cell reconstitution
Online Access:	http://www.sciencedirect.com/science/article/pii/S2772613425000046